For generic drugs, Teva includes future launches in its guidance on a probability-weighted basis unless a product has has a certain launch date stemming from a patent expiration or a legal settlement with the branded-drug company.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”